ARCHIVES

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical Trials System “Slowly Unraveling,”

March 7, 2008

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Ultrasound Reported Accurate in Screen For Prostate Cancer

April 25, 1986

Non-Invasive Test May Detect Lung Cancer In Early Stages

September 26, 2003

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983